Rheumatoid Factor Solution

• Description:

  Rheumatoid Factor Solution_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	S2010001
  Lot number:	Batch dependent
  Expiration date:	Batch depdendent
  Concentration:	‰¥1500 IU/mL
  Package Size:	1 mL
  Appearance:	Slightly turbid
  Species:	Human
  Matrix:	Defibrinated human plasma
  Storage:	-20°C. Avoid repeated freeze-thaw.
  Other names:	RF, rheumatoid arthritis factor, rheumatoid arthritis antibody
  Keywords:	Rheumatoid Factor, RF, rheumatoid arthritis factor, rheumatoid arthritis antibody

  _x000D_

  All Interference Products Brochure_x000D_

  _x000D_ _x000D_ _x000D_ References_x000D_ _x000D_

  _x000D_
  • Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. Annals of Internal Medicine, 68(5), 1195.
  _x000D_
  • Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. Rheumatoid Arthritis, 337€“349.
  _x000D_
  • Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. Rheumatology International, 8(3), 95€“100.
  _x000D_
  • Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis and Rheumatism, 36(1), 1€“6.
  _x000D_
  • Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. Evid Based Complement Alternat Med. 2020 Apr 2;2020:4348709.
  _x000D_
  • Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020 Mar 19. pii: S0049-0172(20)30079-2.
  _x000D_
  • Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites. 2020 Mar 13;10(3). pii: E107.
  _x000D_
  • Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2). pii: E475.
  _x000D_
  • Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020 Apr 3;9(4). pii: E880.
  _x000D_
  • Capone A, Volpe E. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. Front Immunol. 2020 Mar 12;11:348.
  _x000D_

  _x000D_ Related Products to Rheumatoid Factor Solution_x000D_ _x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-diluent/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-blocker-rf/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/triglyceride-mix/_x000D_ _x000D_  

• Short Description:

  Catalog #: S2010001 (1 mL)_x000D_ Rheumatoid Factor Solution consists of human plasma containing high level of RF (at least 1000 IU/mL). It can be used to test the RF tolerance of immunoassays. Custom bulk orders of this product are available upon request._x000D_ _x000D_ Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am - 8 pm PST)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5